Immunology of age-related macular degeneration
Open Access
- 24 May 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 13 (6), 438-451
- https://doi.org/10.1038/nri3459
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular DegenerationACS Nano, 2013
- DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88Cell, 2012
- Short-interfering RNAs Induce Retinal Degeneration via TLR3 and IRF3Molecular Therapy, 2012
- Interleukin-1β Inhibition Prevents Choroidal Neovascularization and Does Not Exacerbate Photoreceptor DegenerationThe American Journal of Pathology, 2011
- Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligandsNature, 2010
- Progression of Geographic Atrophy and Genotype in Age-Related Macular DegenerationOphthalmology, 2010
- The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visitedProgress in Retinal and Eye Research, 2010
- 4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cellsArchives of Biochemistry and Biophysics, 2008
- Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degenerationExperimental Eye Research, 2008
- Physiology of the choroidal vascular bedInternational Ophthalmology, 1983